SLC5A2 and diabetic cardiomyopathy: In diabetic cardiomyopathy models in mice and rats, heart failure models in zebrafish embryos, and a myocardial ischemia model in rats, SGLT-2 inhibitors have been found to ameliorate cardiac histopathologic alterations [78].